Filing Flows

Filing Flows › Pfizer (PFE) › Recalls, complaints & regulation

Pfizer (PFE): recalls, EPA violations, clinical trials and Federal Register

Pfizer (PFE) beyond its filings: 3 recalls in the last 12 months (37 in five years, 10 Class I); 2 EPA-regulated facilities in violation, no penalties in five years; 15 Federal Register documents in a year; 242 active clinical trials.

Latest recalls

EPA facilities in violation

Facility (as registered)CityStatusPenalties
PFIZER PHARMACEUTICALSGuayama, PRSignificant Violation—
HOSPIRA, INC.Rocky Mount, NCViolation Identified—

Facilities in the EPA's ECHO register whose registered name matches the company's; a facility can belong to another business of the same name.

Pfizer's latest quarter

Pfizer, Q3 2026: revenue $16.6B (-0.4% year over year), operating margin 20.4%, net earnings $3.3B, operating cash flow $5.4B. The chart follows the revenue to costs, profit and cash.

Questions

Has Pfizer had any recalls?

37 recalls on file over five years from the FDA, CPSC and NHTSA; 3 in the last 12 months.

Has Pfizer been fined by the EPA?

The 40 EPA-regulated facilities on file under its name drew no penalties in five years; 2 are in violation now.

How many clinical trials does Pfizer have?

242 active studies on ClinicalTrials.gov, 91 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.